Pharmacovigilance Intern
ProPharma
About this role
ProPharma Group is a consulting firm that supports biotech, medical device, and pharmaceutical organizations across the product lifecycle. The Pharmacovigilance Intern role in Hyderabad is a 12-month onsite internship within the Pharmacovigilance department, offering foundational exposure to drug safety and regulatory reporting. The position includes mentorship and training to help build a career in drug safety and regulatory affairs.
Skills
Qualifications
About ProPharma
propharmagroup.comProPharma helps navigate the complexities of drug development and ensure patient health and safety throughout the product lifecycle.
Recent company news
PR NewswireProPharma Expands Operations with New Office in Hyderabad
Dec 11, 2025
Clinical Trials ArenaProPharma's award-winning strategic acquisition and expansion
Sep 24, 2024
ABC11 Raleigh-DurhamNew global headquarters for ProPharma coming to downtown Raleigh
Apr 12, 2023
The Business JournalsProPharma relocates Overland Park headquarters to North Carolina
Apr 25, 2023
PRWebProPharma Group and The Planet Group Announce Executive Leadership Changes and Branding of Combined Company
Sep 9, 2023
About ProPharma
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for ProPharma.
Salary
$49k – $68k
per year
More jobs at ProPharma
Similar Jobs
Pharmacovigilance - Operations & Global Process Enablement Intern
MSD
Intern - Life Sciences Advisory, Health Segment - Campus 2026
Guidehouse
Intern-Medical Safety & Pharmacovigilance
AskBio
Intern - Regulatory Affairs
Fresenius Kabi
Regulatory Affairs Intern - Summer 2026
AstraZeneca
Internship: Pharmacovigilance Trainee, Portugal, 2026
GSK plc